Antibiotic Use patterns and Chlamydia Prevalence in Gynecological Settings: An Observational Study

Introduction

Antibiotic resistance poses a critically important global health threat,​ necessitating a thorough understanding of antibiotic prescribing patterns, particularly in settings where common infections are treated. Gynecological departments frequently⁢ manage infections that require antibiotic intervention, making them a crucial area​ for ‌studying antibiotic use. Chlamydia trachomatis remains a prevalent sexually ⁣transmitted infection (STI) globally, and its management ⁣relies heavily on ⁢appropriate antibiotic therapy. This study aims too investigate the patterns of antibiotic use ​among women attending‍ a ⁢gynecological department ​and to explore⁣ the association between ​prior antibiotic use and the prevalence‍ of current chlamydia infections. Understanding these⁤ relationships is vital for informing‍ antimicrobial stewardship efforts ⁣and improving patient outcomes.

Methods

Study Design and Participants

This observational study included women who visited a⁤ gynecological department within a 12-month⁤ period.​ Participants where surveyed regarding their antibiotic use in the preceding 12 months.

Data Collection

Participants were asked about their use⁤ of seven specific antibiotics:⁤ azithromycin, amoxicillin, erythromycin, clindamycin,⁤ benzylpenicillin, metronidazole,​ and ceftriaxone. For each antibiotic,‌ participants could respond⁣ with “yes,” “no,” or “unsure.” Only explicit “yes” responses were classified‌ as antibiotic‌ use. These ⁤seven antibiotics were selected due to their extensive use in gynecological department settings.

The selection of azithromycin, amoxicillin,⁣ and erythromycin for chlamydia treatment⁤ is ⁤guided ‍by⁣ established clinical guidelines. azithromycin​ is the recommended first-line treatment for chlamydia infection, with erythromycin serving as an choice regimen for ⁢adolescents ‌and adults.Amoxicillin is also ⁣an alternative ⁣regimen, particularly for pregnant⁢ women [5].

Antibiotics were​ further categorized according​ to the World Health Institution (WHO)​ AWaRe (Access, Watch, Reserve) system. The “Access” group included amoxicillin, clindamycin, benzylpenicillin, and metronidazole, which are recommended as empiric first or second-choice treatment ‍options ⁢for common infections. The ‌”Watch” group comprised azithromycin, ceftriaxone, and erythromycin, ⁣which are⁣ typically reserved for specific indications. Reserve antibiotics were not applicable in this study [19].

Current chlamydia and gonorrhea infections⁢ were persistent by positive urine and/or cervical swab results. High-risk sexual behaviors were defined as ever having a casual ⁣sex partner and/or not consistently using condoms during sexual ‍intercourse.

Statistical Analysis

Baseline characteristics ⁢of participants were compared between those who ⁣reported antibiotic ⁤use and those who ⁢did not,‍ using Pearson’s chi-squared test for categorical variables. Data were‍ presented as‍ counts and percentages. Missing data ⁤for baseline characteristics were handled by grouping them⁣ into a separate ​category for each variable. The proportion of use for each antibiotic was calculated.

the association between prior antibiotic use and the prevalence of chlamydia infection was assessed using multivariable logistic regression.​ Odds ratios (ORs) with their ‌corresponding 95% confidence intervals (CIs) were calculated, adjusting for age, age at first sexual debut, and ​high-risk sexual behaviors. For antibiotics specifically recommended for chlamydia ⁣treatment (azithromycin, erythromycin, amoxicillin), a⁣ subgroup​ analysis was conducted among users of these agents to evaluate class-specific ⁣effects.

All statistical⁢ analyses were performed​ using R software (version 4.3.2; ‌R Core Team, 2023). A two-sided P value of less than 0.05 was considered statistically significant.

Results

(This section would typically ‍present the findings of the study, including demographic characteristics of the participants, the prevalence of antibiotic use for each of the seven antibiotics, the proportion ⁣of participants with current​ chlamydia and gonorrhea infections, and the results of the logistic⁢ regression analysis showing the association between ‍antibiotic use and chlamydia prevalence. It would ⁢also detail the​ findings⁢ of ⁤the subgroup analysis for ​chlamydia-specific antibiotics.)

Discussion

(This section would interpret the study’s ‍findings in the context of existing literature.It would discuss the observed antibiotic use patterns,potential reasons for these patterns,and the implications ⁣of the association⁣ between antibiotic use ⁣and chlamydia prevalence. The discussion would also address the strengths and limitations ⁢of the study, ‍such as⁣ the reliance on self-reported antibiotic use and the potential for confounding factors. Recommendations for antimicrobial‍ stewardship ⁢and future research directions would ‌also be included here.)

Conclusion

(This section would summarize the main findings of the study and reiterate the key takeaways regarding antibiotic use and chlamydia prevalence in the studied gynecological setting. It would emphasize the importance ‌of understanding antibiotic prescribing practices for effective management of STIs and combating antimicrobial resistance.)

References

[5] Qianqiu W